JENNIFER VASQUEZ: Open Payments
NPI 1316207392 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 17 payments from 10 companies in 2025. Trend: 2023 $394 · 2024 $1,022 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $223 |
| Paratek Pharmaceuticals, Inc. | 3 | $143 |
| Xeris Pharmaceuticals, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Exeltis, USA Inc. | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Hologic Sales and Service, LLC | 1 | $23 |
| AXOGEN | 1 | $21 |
| Exact Sciences Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
Products named: Ozempic, NUZYRA, GVOKE HYPOPEN, TWIRLA, REXULTI, APTIMA, Cologuard Collection Kit, MOUNJARO.
Industry payments across OK — which companies pay providers there.
